Fredun Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Fredun Pharmaceuticals Ltd. on BSE

Search Inside the pdf :

Fredun Pharmaceuticals Ltd.

23 Aug 2025

1150.25

0.71%

Company Update

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Pursuant to Regulation 30 read with sub para 15, Para A Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Senior Management Team of the Company will participate in the Analyst/Investor meeting.

pdf

Fredun Pharmaceuticals Ltd.

06 Aug 2025

1150.25

0.71%

Earnings Call

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

TRANSCRIPT OF THE EARNINGS CONFERENCE CALL HELD ON 1ST AUGUST 2025 FOR Q1 FY26 RESULTS.

pdf

Fredun Pharmaceuticals Ltd.

01 Aug 2025

1150.25

0.71%

Earnings Call

Fredun Pharmaceuticals Ltd - 539730 - Audio Recording Of The Q1 FY26 'Earnings Conference Call'

BSE India

Audio Recording of the Q1 FY26 "Earnings Conference Call"

pdf

Fredun Pharmaceuticals Ltd.

01 Aug 2025

1150.25

0.71%

Earnings Call

Fredun Pharmaceuticals Ltd - 539730 - Audio Recording Of The Q1 FY25 'Earnings Conference Call'

BSE India

Audio Recording of the Q1 FY25 "Earnings Conference Call"

pdf

Fredun Pharmaceuticals Ltd.

31 Jul 2025

1150.25

0.71%

Company Update

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press release issued by Fredun Pharmaceuticals Limited.

pdf

Fredun Pharmaceuticals Ltd.

30 Jul 2025

1150.25

0.71%

Company Update

Fredun Pharmaceuticals Ltd - 539730 - Appointment Of Non-Executive Independent Directors.

BSE India

Appointment of Non-Executive Independent Directors Mr. Anshu Agarwal and Mrs. Sonal Desai.

pdf

Fredun Pharmaceuticals Ltd.

30 Jul 2025

1150.25

0.71%

Company Update

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Change in Directorate

BSE India

Appointment of non-excecutive Independent Directors.

pdf

Fredun Pharmaceuticals Ltd.

30 Jul 2025

1150.25

0.71%

Company Update

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Appointment of Non-Executive Independent Directors Mr. Anshu Agarwal and Mrs. Sonal Desai.

pdf

Fredun Pharmaceuticals Ltd.

30 Jul 2025

1150.25

0.71%

Result

Fredun Pharmaceuticals Ltd - 539730 - Results For The Quarter Ended 30Th June 2025.

BSE India

Un-audited Results of the Company for the quarter ended 30th June 2025 along with Limited review report.

pdf

	Jun 2025	Mar 2025	Jun 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	119.86	167.41	78.81	-28.4%	52.1%
Operating Profit Qtr	16.54	15.47	9.20	6.9%	79.8%
Net Profit Qtr	6.77	7.07	4.13	-4.2%	63.9%
Earning Per Share Adjusted latest Qtr	14.33	14.98	8.75	-4.3%	63.8%

* Standalone data

Detailed Results

Fredun Pharmaceuticals Ltd.

30 Jul 2025

1150.25

0.71%

Board Meeting

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Outcome for Outcome Of Board Meeting

BSE India

Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Wednesday, July 30, 2025 has inter-alia, considered, adopted and approved following items of business: 1. In compliance to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Un-Audited Financial Results of the Company for the quarter ended 30th June, 2025 along with the Limited Review Report as issued by M/s. R.H. Nisar & Co, Statutory Auditors of the Company; copies of which are attached hereunder; 2. The Board of Directors have, vide Resolution dated 30th July, 2025 have appointed Mr. Anshu Agarwal (DIN: 11206436) and Ms. Sonal Desai (DIN: 11167642) as an Additional Director in the category of Independent Director of the Company for a term of five years.

pdf

Is Fredun Pharmaceuticals Ltd. worth buying?

31 Votes:

Buy 70.97%

Sell 19.35%

Hold 9.68%

RESEARCH REPORTS

Not Rated SEE REPORTS >

pdf link